×
About 7,335 results

ALLMedicine™ Acne Vulgaris Center

Research & Reviews  2,859 results

Essential Oil and Juice from Bergamot and Sweet Orange Improve Acne Vulgaris Caused by ...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7559496
Mediators of Inflammation; Sun P, Zhao L et. al.

Oct 21st, 2020 - Acne vulgaris is one of the most common chronic inflammatory skin diseases. Bergamot and sweet orange are rich in nutritional and functional components, which exhibit antioxidant, anti-inflammatory, and antiapoptotic effect. The aim of this study ...

Topical dermocosmetics and acne vulgaris.
https://doi.org/10.1111/dth.14436
Dermatologic Therapy; Conforti C, Giuffrida R et. al.

Oct 21st, 2020 - acne is a highly common skin disease especially among teenagers. Modern acne treatments are based also on the use of moisturizers, cleansers and sunscreens. In choosing the right cleanser, it is important to consider some aspects: the interaction ...

Medication adherence and its possible associated factors in patients with acne vulgaris...
https://doi.org/10.1111/dth.14408
Dermatologic Therapy REFERENCES; Salamzadeh J, Torabi Kachousangi S et. al.

Oct 21st, 2020 - There are several etiologic factors involved in the pathogenesis of acne vulgaris. Therefore, current treatment guidelines recommend applying different classes of medications for it. This makes medication adherence a challenging issue in acne pati...

Systematic review of low-dose Isotretinoin for treatment of acne vulgaris: focus on ind...
https://doi.org/10.1111/dth.14438
Dermatologic Therapy; Sadeghzadeh-Bazargan A, Ghassemi M et. al.

Oct 21st, 2020 - Oral isotretinoin is the most effective treatment for moderate to severe acne and its side effects are mostly dose-dependent. Low dose isotretinoin (0.5 mg/kg per day for 1 week every 4 weeks for 6-month) could be effective and even in its end res...

A split-face comparative trial of photopneumatic therapy versus intense pulsed light fo...
https://doi.org/10.1080/14764172.2020.1827149
Journal of Cosmetic and Laser Therapy : Official Publication of the European Society for Laser Dermatology; Kim JE, Park BJ et. al.

Oct 19th, 2020 - A novel photopneumatic (PPX) technology, combining blue light-emitting diode (LED) and broadband intense pulsed light (IPL) with vacuum pressure, was developed for the treatment of acne vulgaris (AV). In this study, we enrolled 50 patients with mi...

see more →

Guidelines  29 results

Foamix Receives FDA Approval of AMZEEQ™ Topical Minocycline Treatment for Millions of Moderate to Severe Acne Sufferers
https://www.foamix.com/news-releases/news-release-details/update-foamix-receives-fda-approval-amzeeqtm-topical-minocycline

Oct 17th, 2019 - Foamix Pharmaceuticals Ltd. (Nasdaq: FOMX) (“Foamix” or the “Company”), a specialty pharmaceutical company, today announced that the U.S. Food and Drug Administration (FDA) has approved its novel AMZEEQTM (minocycline) topical foam, 4%. AMZEEQ, fo...

Acne Vulgaris: Diagnosis and Treatment
https://www.aafp.org/afp/2019/1015/p475.html
American Family Physician;

Oct 14th, 2019 - Acne vulgaris is the most prevalent chronic skin disease in the United States, affecting nearly 50 million people per year, mostly adolescents and young adults. Potential sequelae of acne, such as scarring, dyspigmentation, and low self-esteem, ma...

FDA approves Aklief for acne on face, trunk
https://www.healio.com/dermatology/acne/news/online/%7Bcc693b23-e6fc-4919-a303-fc14f62279b4%7D/fda-approves-aklief-for-acne-on-face-trunk

Oct 3rd, 2019 - The FDA recently approved Galderma’s topical retinoid cream, known as Aklief, for the treatment of acne vulgaris. Additionally, the company reported positive safety profiles for Aklief in two phase 3 clinical trials on acne of both the face and tr...

Oral isotretinoin for acne
https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD009435.pub2/full
Riera,R.,etal

Nov 23rd, 2018 - Acne vulgaris, a chronic inflammatory disease of the pilosebaceous unit associated with socialisation and mental health problems, may affect more than 80% of teenagers. Isotretinoin is the only drug that targets all primary causal factors of acne;...

Acne Vulgaris - StatPearls
https://www.ncbi.nlm.nih.gov/books/NBK459173/
Sutaria,A.,et al

Nov 13th, 2018 - Acne vulgaris is an inflammatory disorder of pilosebaceous unit, which runs a chronic course and it is self-limiting. Acne vulgaris is triggered by Propionibacterium acnes in adolescence, under the influence of normal circulating dehydroepiandrost...

see more →

Drugs  667 results see all →

Clinicaltrials.gov  3,527 results

Essential Oil and Juice from Bergamot and Sweet Orange Improve Acne Vulgaris Caused by ...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7559496
Mediators of Inflammation; Sun P, Zhao L et. al.

Oct 21st, 2020 - Acne vulgaris is one of the most common chronic inflammatory skin diseases. Bergamot and sweet orange are rich in nutritional and functional components, which exhibit antioxidant, anti-inflammatory, and antiapoptotic effect. The aim of this study ...

Topical dermocosmetics and acne vulgaris.
https://doi.org/10.1111/dth.14436
Dermatologic Therapy; Conforti C, Giuffrida R et. al.

Oct 21st, 2020 - acne is a highly common skin disease especially among teenagers. Modern acne treatments are based also on the use of moisturizers, cleansers and sunscreens. In choosing the right cleanser, it is important to consider some aspects: the interaction ...

Medication adherence and its possible associated factors in patients with acne vulgaris...
https://doi.org/10.1111/dth.14408
Dermatologic Therapy REFERENCES; Salamzadeh J, Torabi Kachousangi S et. al.

Oct 21st, 2020 - There are several etiologic factors involved in the pathogenesis of acne vulgaris. Therefore, current treatment guidelines recommend applying different classes of medications for it. This makes medication adherence a challenging issue in acne pati...

Systematic review of low-dose Isotretinoin for treatment of acne vulgaris: focus on ind...
https://doi.org/10.1111/dth.14438
Dermatologic Therapy; Sadeghzadeh-Bazargan A, Ghassemi M et. al.

Oct 21st, 2020 - Oral isotretinoin is the most effective treatment for moderate to severe acne and its side effects are mostly dose-dependent. Low dose isotretinoin (0.5 mg/kg per day for 1 week every 4 weeks for 6-month) could be effective and even in its end res...

A split-face comparative trial of photopneumatic therapy versus intense pulsed light fo...
https://doi.org/10.1080/14764172.2020.1827149
Journal of Cosmetic and Laser Therapy : Official Publication of the European Society for Laser Dermatology; Kim JE, Park BJ et. al.

Oct 19th, 2020 - A novel photopneumatic (PPX) technology, combining blue light-emitting diode (LED) and broadband intense pulsed light (IPL) with vacuum pressure, was developed for the treatment of acne vulgaris (AV). In this study, we enrolled 50 patients with mi...

see more →

News  253 results

CUTIS Celebrates 55 Years
https://www.mdedge.com/dermatology/article/217608/cutis-celebrates-55-years

Feb 20th, 2020 - When the first issue of Cutis was published in February 1965: Alopecia was featured on the cover Eugene F. Traub, MD, was Chief Editor, and John T.

Product News February 2020
https://www.mdedge.com/dermatology/article/217153/product-news-february-2020

Feb 12th, 2020 - Arazlo Lotion Approved for Acne Vulgaris Ortho Dermatologics announces US Food and Drug Administration approval of Arazlo (tazarotene) Lotion 0. 045% for the topical treatment of acne vulgaris in patients 9 years and older.

Product News November 2019
https://www.mdedge.com/dermatology/article/211999/psoriasis?channel=38029

Nov 11th, 2019 - Aklief Cream Topical Retinoid Approved for Acne Vulgaris Galderma Laboratories, LP, announces US Food and Drug Administration approval of Aklief (trifarotene) Cream 0. 005% for the treatment of acne vulgaris in patients 9 years and older.

FDA approves minocycline foam for moderate, severe acne
https://www.mdedge.com/internalmedicine/article/210605/acne/fda-approves-minocycline-foam-moderate-severe-acne?channel=39313
Lucas Franki

Oct 22nd, 2019 - The Food and Drug Administration has approved topical minocycline (Amzeeq) foam, 4%, for the treatment of inflammatory lesions associated with nonnodular moderate to severe acne vulgaris in adults and pediatric patients aged at least 9 years. Oliv.

Foamix Receives FDA Approval of AMZEEQ™ Topical Minocycline Treatment for Millions of Moderate to Severe Acne Sufferers
https://www.foamix.com/news-releases/news-release-details/update-foamix-receives-fda-approval-amzeeqtm-topical-minocycline

Oct 17th, 2019 - Foamix Pharmaceuticals Ltd. (Nasdaq: FOMX) (“Foamix” or the “Company”), a specialty pharmaceutical company, today announced that the U.S. Food and Drug Administration (FDA) has approved its novel AMZEEQTM (minocycline) topical foam, 4%. AMZEEQ, fo...

see more →